New Key Statistics Module, Z-Score and F-Score
OTCPK:ELTP Key Ratios
| Market Cap $ M | 384.69 |
| Enterprise Value $ M | 432.70 |
| P/E(ttm) | 30.01 |
| PE Ratio without NRI | 22.51 |
| Forward PE Ratio | -- |
| Price/Book | 6.00 |
| Price/Sales | 5.77 |
| Price/Free Cash Flow | 360.11 |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 66.00 |
| EPS (TTM) $ | 0.01 |
| Beneish M-Score | 1.05 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -62.50 |
| EV-to-EBIT | 588.71 |
| EV-to-EBITDA | 177.99 |
| PEG | -- |
| Shares Outstanding M | 1,068.27 |
| Net Margin (%) | 29.47 |
| Operating Margin % | 19.64 |
| Pre-tax Margin (%) | 0.02 |
| Quick Ratio | 2.09 |
| Current Ratio | 3.08 |
| ROA % (ttm) | 26.94 |
| ROE % (ttm) | 41.23 |
| ROIC % (ttm) | 33,562.56 |
| Dividend Yield % | -- |
| Altman Z-Score | 6.13 |
ELTP Number of Guru Trades
ELTP Volume of Guru Trades
Gurus Latest Trades with OTCPK:ELTP
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:ELTP is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Elite Pharmaceuticals Inc Insider Transactions
No Available Data
News about OTCPK:ELTP
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers